Acthar
Links shared publicly online about this topic
FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms
drugs.com — “H.P. Acthar Gel (repository corticotropin injection) is used to treat infantile spasms. Includes H.P. Acthar Gel side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 12:33 am By:
FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms - http://bit.ly/cZqKuz
H.P. Acthar Gel approved for infantile spasms - MPR
empr.com — “Questcor announced that the FDA has approved H.P. Acthar Gel (repository corticotropin injection) for the treatment of infantile spasms.” View full resource at empr.com
Most Recently Shared on October 15, 2010 at 5:09 pm By:
MPR News: H.P. Acthar Gel approved for infantile spasms: Questcor announced that the FDA has approved H.P. Acthar ... http://bit.ly/bFcwkN
UPDATE 2-US FDA panel backs Questcor's Acthar
us.mobile.reuters.com — “UPDATE 2-US FDA panel backs Questcor's Acthar” View full resource at us.mobile.reuters.com
Most Recently Shared on May 7, 2010 at 8:56 pm By:
Jeff Kraakevik Neurologist, Physician, and Doctor
RT @doc4hd: Check out my quote: US FDA panel backs Questcor's Acthar: http://bit.ly/bBEIja = One solid quote, you da man. ;)
H.P. Acthar Gel approved for infantile spasms - ONA
oncologynurseadvisor.com — “Questcor announced that the FDA has approved H.P. Acthar Gel (repository corticotropin injection) for the treatment of infantile spasms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 15, 2010 at 5:03 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
H.P. Acthar Gel approved for infantile spasms http://goo.gl/fb/f44rD
Questcor announces launch of H.P. Acthar Gel for infantile spasms
news-medical.net — “Questcor Pharmaceuticals, Inc. today announced that the commercial launch is now underway for H.P. Acthar® Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms (IS) in infants and children under the age of two years. This new Acthar indication was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2010.” View full resource at news-medical.net
Most Recently Shared on November 3, 2010 at 4:24 pm By:
Epilepsy News: Questcor announces launch of H.P. Acthar Gel for infantile spasms: Questcor Pharmaceuticals, Inc. t... http://bit.ly/aHKU91
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms
medicalnewstoday.com — “Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repo” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2010 at 1:05 pm By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms http://mnt.to/3Lkr #pediatrics
Acute Multiple Sclerosis - H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations
medicalnewstoday.com — “A presentation at the American Society of Nephrology 44th Annual Meeting, showed study results of H.P. Acthar® Gel, a natural adrenocorticotropic hormone (ACTH) designed for treatment of acute” View full resource at medicalnewstoday.com
Most Recently Shared on November 13, 2011 at 8:05 am By:
Acute Multiple Sclerosis - H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations http://t.co/2ygfEhTK #multiplesclerosis
FDA advisers support Acthar as treatment for infantile spasms - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel endorsed the approval of Questcor Pharmaceuticals' injectable gel Acthar for infantile spasms. The drug is already approved for other indications, including multiple sclerosis. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ereuters%2ecom%2farticle%2fidUSN0626892720100506&id2=aa br” View full resource at smartbrief.com
Most Recently Shared on May 8, 2010 at 4:44 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA advisers support Acthar as treatment for infantile spasms http://sbne.ws/r/4EWy
FDA sets June target for decision on wider use of Questcor's Acthar - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA has scheduled its approval decision on a new indication for Questcor Pharmaceuticals' Acthar for June 11. Questcor is seeking to market the multiple sclerosis drug for use in infantile spasms. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ereuters%2ecom%2farticle%2fidUSTRE5BN1SP2009122” View full resource at smartbrief.com
Most Recently Shared on December 28, 2009 at 11:37 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA sets June target for decision on wider use of Questcor's Acthar http://sbne.ws/r/3xSg
FDA Approves H.P. Acthar Gel For The Treatment Of Infantile Spasms - QualityPoint Technologies
qualitypointtech.net — “Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood...” View full resource at qualitypointtech.net
Most Recently Shared on October 16, 2010 at 10:33 pm By:
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms: Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR... http://bit.ly/9nP5VZ
Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel
news-medical.net — “Questcor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has informed Questcor that the FDA will require additional time beyond the current action date of September 11, 2010 to complete its review of Questcor's supplemental new drug application for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms.” View full resource at news-medical.net
Most Recently Shared on September 9, 2010 at 11:56 am By:
Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel: Questcor Pharmaceuticals, Inc. today announc... http://bit.ly/c1LGHD
Interim Results From Independent Study Of H.P. Acthar® Gel In Patients With Advanced Diabetic Nephropathy Presented At American Society Of Nephrol
medicalnewstoday.com — “On November 20 at the American Society of Nephrology (ASN) 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A. Tumlin,” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2010 at 7:05 pm By:
Interim Results From Independent Study Of H.P. Acthar® Gel In Patients With Advanced Diabetic Nephropathy Presente... http://mnt.to/3N3B
Questcor Pharmaceuticals says HP Acthar gel gets FDA approval for infantile spasms indication | Markets | Market News | Canadian Business Online
canadianbusiness.com — “Questcor Pharmaceuticals Inc. said Friday the Food and Drug Administration approved H.P. Acthar Gel” View full resource at canadianbusiness.com
Most Recently Shared on October 15, 2010 at 6:39 pm By:
RT @KimPainter: FDA has just approved long-used-off-label med for a rare form of #epilepsy (ACTH for infantile spasms) http://bit.ly/8Ysmz0
New Data on H.P. Acthar Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Nephrology 43rd Annual Meeting - Drugs.com MedNews
drugs.com — “Analysis included patients with advanced kidney disease who Results in idiopathic membranous nephropathy, one of the more On November 20 at the American Society” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 1:10 pm By:
Drugs and Devices OW OW Health
New Data on H.P. Acthar Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Ne... http://bit.ly/dxNqq0 #drug
Interim Results From Independent Study of H.P. Acthar Gel in Patients With Advanced Diabetic Nephropathy Presented at American Society of Nephrology 43rd Annual Meeting - Drugs.com MedNews
drugs.com — “New data suggest Acthar may represent a novel pathway for the Diabetic nephropathy represents the most common cause of On November 20 at the American Society of” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 1:10 pm By:
Drugs and Devices OW OW Health
Interim Results From Independent Study of H.P. Acthar Gel in Patients With Advanced Diabetic Nephropathy P... http://bit.ly/8YbqD7 #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Jeff Kraakevik
Academic neurologist from Oregon focused on Mov Dis and med student edu. Views expressed are my own and do not necessarily reflect my employer's. (Phew!)
Advertisement
